CHEBI:68845 - azilsartan medoxomil

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name azilsartan medoxomil
Definition A carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C30H24N4O8
Net Charge 0
Average Mass 568.53360
Monoisotopic Mass 568.15941
InChI InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36)
SMILES CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1noc(=O)[nH]1
Roles Classification
Biological Role(s): angiotensin receptor antagonist
A hormone antagonist that blocks angiotensin receptors.
Application(s): prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
angiotensin receptor antagonist
A hormone antagonist that blocks angiotensin receptors.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing azilsartan medoxomil (CHEBI:68845) has functional parent azilsartan (CHEBI:68850)
azilsartan medoxomil (CHEBI:68845) has role angiotensin receptor antagonist (CHEBI:61016)
azilsartan medoxomil (CHEBI:68845) has role antihypertensive agent (CHEBI:35674)
azilsartan medoxomil (CHEBI:68845) has role prodrug (CHEBI:50266)
azilsartan medoxomil (CHEBI:68845) is a 1,2,4-oxadiazole (CHEBI:46809)
azilsartan medoxomil (CHEBI:68845) is a aromatic ether (CHEBI:35618)
azilsartan medoxomil (CHEBI:68845) is a benzimidazoles (CHEBI:22715)
azilsartan medoxomil (CHEBI:68845) is a carboxylic ester (CHEBI:33308)
azilsartan medoxomil (CHEBI:68845) is a cyclic carbonate ester (CHEBI:46838)
azilsartan medoxomil (CHEBI:68845) is a dioxolane (CHEBI:39430)
azilsartan medoxomil (CHEBI:68845) is conjugate acid of azilsartan medoxomil(1−) (CHEBI:68849)
Incoming azilsartan medoxomil(1−) (CHEBI:68849) is conjugate base of azilsartan medoxomil (CHEBI:68845)
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1-benzimidazole-7-carboxylate
INNs Sources
azilsartan médoxomil WHO MedNet
azilsartan medoxomil WHO MedNet
azilsartán medoxomilo WHO MedNet
azilsartanum medoxomilum WHO MedNet
Brand Name Source
Edarbi ChEBI
Manual Xrefs Databases
4322 DrugCentral
Azilsartan Wikipedia
US2005187269 Patent
View more database links
Registry Numbers Types Sources
12326818 Reaxys Registry Number Reaxys
863031-21-4 CAS Registry Number ChemIDplus
863031-21-4 CAS Registry Number KEGG DRUG
Citations Waiting for Citations Types Sources
21069103 PubMed citation Europe PMC
21272195 PubMed citation Europe PMC
21282560 PubMed citation Europe PMC
21555300 PubMed citation Europe PMC
21558880 PubMed citation Europe PMC
21566544 PubMed citation Europe PMC
21762358 PubMed citation Europe PMC
21816148 PubMed citation Europe PMC
21971539 PubMed citation Europe PMC
21986624 PubMed citation Europe PMC
22071238 PubMed citation Europe PMC
22116996 PubMed citation Europe PMC
22346296 PubMed citation Europe PMC
22365278 PubMed citation Europe PMC
22457601 PubMed citation Europe PMC
22533654 PubMed citation Europe PMC
22661897 PubMed citation Europe PMC
22710649 PubMed citation Europe PMC
22877322 PubMed citation Europe PMC
22939358 PubMed citation Europe PMC
Last Modified
22 February 2017